J-A22040-19

                                   2019 PA Super 310


    BEONCA MARIA MCCONNELL, AN                 :   IN THE SUPERIOR COURT OF
    INDIVIDUAL,                                :        PENNSYLVANIA
                                               :
                       Appellant               :
                                               :
                                               :
                v.                             :
                                               :
                                               :   No. 2971 EDA 2018
    B. BRAUN MEDICAL INC., A                   :
    PENNSYLVANIA CORPORATION, B.               :
    BRAUN INTERVENTIONAL SYSTEMS               :
    INC., A DELAWARE CORPORATION,              :
    AND B. BRAUN MEDICAL S.A.S., A             :
    FRENCH CORPORATION                         :

                 Appeal from the Order Dated August 21, 2018
      In the Court of Common Pleas of Philadelphia County Civil Division at
                    No(s): June Term, 2017 No. XX-XXXXXXX


BEFORE: MURRAY, J., STRASSBURGER, J.*, and PELLEGRINI, J.*

OPINION BY PELLEGRINI, J.:                             FILED OCTOBER 16, 2019

        The Appellant, Beonca Maria McConnell (McConnell), appeals the order

of the Court of Common Pleas of the Philadelphia County (trial court)

dismissing her products liability suit against B. Braun Medical Inc. (BMI); B.

Braun Interventional Systems, Inc. a Delaware Corporation (BIS); and B.

Braun Medical S.A.S., a French Corporation (B. Braun France) (collectively,

the Braun Defendants), on the ground of forum non conveniens. McConnell

argues that the trial court abused its discretion because the Braun Defendants

____________________________________________


*   Retired Senior Judge assigned to the Superior Court.
J-A22040-19


failed to show that Pennsylvania is an inconvenient forum for her claims. For

the reasons below, we vacate the order dismissing her case.1

                                               I.

        McConnell’s products liability action arises from the implantation of a

“VenaTech LP Vena Cava Filter” (VenaTech Filter).2 It is undisputed that at

the time of the implantation in 2003, McConnell resided in Michigan where the

procedure was performed.          Between 2008 and 2013, McConnell resided in

North Carolina. In 2015, while residing in Texas, McConnell underwent a CT

scan that allegedly revealed that the VenaTech Filter had caused recoverable

damages.

        According to McConnell’s complaint, the device is designed to be

implanted in a person’s inferior vena cava, a central vein in the heart.

Complaint, 6/16/2017, at ¶ 18. The device’s purpose is to prevent blood clots

from traveling from the legs and pelvis to the heart and lungs. Id. at ¶ 19.

Once the VenaTech Filter is literally hooked to the heart, it remains fixed in

place permanently and cannot be safely removed. Id. at ¶¶ 20-22.




____________________________________________


1 This appeal is reviewed in conjunction with three related Superior Court
appeals which concern nearly identical points of law and analogous facts:
Zevola v. B. Braun Medical Inc., 3011 EDA 2018; Vars v. B. Braun
Medical Inc., 3052 EDA 2018; and Jeans v. B. Braun Medical Inc., 3071
EDA 2018.

2   The facts are gleaned from the trial court’s opinion and the certified record.


                                           -2-
J-A22040-19


       McConnell asserts that the device “failed” and has “penetrated through

the caval wall,” posing a danger of the fatal medical events the device was

meant to prevent, as well as the risk of further perforation of her heart. Id.

at ¶¶ 23-25. This will require “ongoing medical care and monitoring for the

rest of her life.” Id. at ¶ 25.

       McConnell filed her complaint in 2017 in the trial court setting forth

seven causes of action: Negligence, Strict Products Liability/Failure to Warn,

Strict Products Liability/Design Defect, Strict Products Liability/Manufacturing

Defect,    Breach     of   Implied     Warranty   of   Merchantability,   Negligent

Misrepresentation, and Punitive Damages.

       Within the next year and before the parties began discovery, BMI and

BIS filed a two-part motion based on the doctrine of forum non conveniens.

First, they moved to dismiss McConnell’s complaint, arguing that the suit

should be refiled in her home state of Texas or in Michigan, where the device

was implanted. Alternatively, they sought for the case to be transferred to

Lehigh County, Pennsylvania. Once B. Braun France joined the motion, the

Braun Defendants all consented to a trial in Texas or Michigan; they also

agreed to waive a statute of limitations defense in the event of dismissal.3




____________________________________________


3 The Braun Defendants filed preliminary objections to venue, but the trial
court ruled that venue was proper based on the Braun Defendants’ contacts
with Philadelphia County. This ruling is not now at issue.


                                           -3-
J-A22040-19


      At the hearing on the subject motion, the trial court heard argument

and took evidence on the forum non conveniens issue. It was undisputed that

each of the Braun Defendants had a role in putting the VenaTech Filter into

the stream of commerce, but have varying degrees of local presence in

McConnell’s chosen forum of Philadelphia County.        BMI is a Pennsylvania

corporation with a headquarters in Lehigh County, Pennsylvania.        BIS is a

Delaware corporation with a principal place of business in Lehigh County. B.

Braun France is a French corporation with no physical presence in the United

States.

      B. Braun France designed and manufactured the VenaTech Filter, but

the United States Food and Drug Administration (FDA) only approved the

domestic sale and marketing of the device in 2001. From that date and on an

exclusive basis, BMI imported and distributed VenaTech Filters throughout the

United States.

      In 2007, BMI transferred its FDA clearances to BIS, who has since

maintained exclusive rights to the VenaTech Filter in the United States. BMI

and BIS allegedly marketed the device as safe for permanent placement in a

human subject’s heart. Either BMI or BIS marketed and sold the particular

device at issue in McConnell’s suit, along with every other unit of the VenaTech

Filter distributed and sold in the United States since 2001.

      The Braun Defendants emphasized at the hearing on their motion to

dismiss that the VenaTech Filter was designed and manufactured in France;


                                     -4-
J-A22040-19


that McConnell had the VenaTech Filter implanted in Michigan; and that she

has never resided in Pennsylvania.        They claimed that the parties have

minimal connections to Pennsylvania, that Pennsylvania has little interest in

the litigation, and that another forum is available and more convenient for

trial purposes.

       Notably, however, the Braun Defendants had introduced an affidavit by

the president of BIS, Paul O’Connell (O’Connell), who stated that although he

resides in Illinois, other “potentially relevant witnesses from BIS – for

example, the employees who are responsible for distribution, sales, and post-

market surveillance of the VenaTech Filter – reside and work in Lehigh

County.” O’Connell, Affidavit, ¶ 13.

       In the motion, the Braun Defendants identified and described these

potential trial witnesses as follows:

      Doris Benson, a Senior Market and Quality Associate who can
       testify to distribution, sales, post-market surveillance of the
       VenaTech Filter.

      Peter Flosdort, an engineering manager responsible for the
       Quality/Regulatory/Product Development departments, which
       includes “complaint reporting and medical device report” and
       investigation of “non-conforming lots” in the event of a recall.

      Jason Curtis, a Project Manager who is a “Quality” designee for
       BIS in charge of “certain tasks that only he is authorized to
       perform.”


BMI and BIS, Motion to Dismiss or Transfer for Forum Non Conveniens,

8/8/2017, at 9-12. All three of those BIS employees stated in an affidavit



                                        -5-
J-A22040-19


that it would be a hardship for them to leave their homes in Lehigh County in

order to attend a trial 60 miles away in Philadelphia County.4

       Despite that evidence, the trial court dismissed McConnell’s suit. In its

opinion, the trial court found that Pennsylvania has little interest in resolving

McConnell’s products liability claims because “the record indicates – despite

the corporate presence of [BMI and BIS] – the decisions and documentation

for the locus of [McDonnell’s] action arose outside of Pennsylvania.”       Trial

Court Opinion, 2/14/2019, at 10.

       The trial court also outlined several other reasons for granting the

dismissal. It reasoned that if the case were re-filed in McConnell’s home state,

potential difficulties in applying out-of-state law would be avoided and the

presence of witnesses could more easily be ensured. Id. It was presumed

that causation and damages would be hotly contested issues at trial, and that

McConnell’s medical care providers in Texas would be unwilling to attend a

Pennsylvania trial. See id. at 9.5

____________________________________________


4  The Braun Defendants argued that Philadelphia County would be so
inconvenient for these BIS employees that the trial should be transferred to
Lehigh County. The logical conclusion of that claim is that if a trial in
Philadelphia County would be highly disruptive to the lives of those potential
witnesses, then a trial in Texas or Michigan would be even more so.

5 Unlike Pennsylvania, the state of Texas has not adopted the Uniform
Interstate Depositions and Discovery Act (UIDDA), which makes non-party
witnesses subject to compulsory deposition and subpoena by a court in
another state’s jurisdiction. See 42 Pa.C.S. §§ 5331-5371. We note,
however, that the other states found to be better-suited forums for the Braun



                                           -6-
J-A22040-19


       The trial court assigned no weight to the fact that employees of BMI and

BIS made marketing, sale and distribution decisions within Pennsylvania. Id.

at 11-12.       Similarly, the trial court ruled that the existence of any

documentation or evidence in Pennsylvania would be immaterial. Id. at 10-

11. The trial court did not rule on the Braun Defendants’ alternative motion

to transfer the case to Lehigh County.

       McConnell timely appealed and both McConnell and the trial court

complied with Rule 1925. In her brief, McConnell asserts the following issue

for our consideration:

       [D]id the Trial Court misapply the law or render a manifestly
       unreasonably decision by overruling [McConnell’s] right to choose
       her forum and . . . granting the Appellees’ motion to dismiss based
       on forum non conveniens when the public and private factors do
       not weigh strongly against her chosen forum?

Appellant’s Brief, at 5.

       The Braun Defendants urge us to affirm the dismissal order, stressing

as they did below that any relevant conduct in McConnell’s action occurred

outside of Pennsylvania. They argue that McConnell is a Texas resident who

had the subject surgery in Michigan, and that the VenaTech Filter was




____________________________________________


Defendants’ related cases have all adopted the UIDDA. See Miss. Code Ann.
§ 11-59-1(Mississippi); NY C.P.L.R. Law § 3119 (New York); Tenn. Code Ann.
§ 24-9-201(Tennessee); Wash. Rev. Code § 5.51.902 (Washington).




                                           -7-
J-A22040-19


designed and manufactured in France. They echo the trial court’s findings

that a trial in Pennsylvania would be impractical.6

                                               II.

                                               A.

       The doctrine of forum non conveniens allows the dismissal of a case

when the evidence shows that another forum would be more appropriate:

       Inconvenient forum – when a tribunal finds that in the interest of
       substantial justice the matter should be heard in another forum,
       the tribunal may stay or dismiss the matter in whole or in part on
       any conditions that may be just.

42 Pa.C.S. § 5322(e).

       A plaintiff's choice of forum is entitled to deference, but to a somewhat

lesser degree when the plaintiff’s residence and place of injury are located

somewhere else. See Bochetto v. Piper Aircraft Co., 94 A.3d 1044, 1056

(Pa. Super. 2014). In any event, the trial court may grant a motion to dismiss

on the grounds of forum non conveniens only if “weighty reasons” support

disturbing a plaintiff’s choice of forum and an alternative forum is available.

See Jessop v. ACF Industries, LLC, 859 A.2d 801, 803 (Pa. Super. 2004).

“Furthermore, a court will . . . not dismiss for forum non conveniens unless


____________________________________________


6The Braun Defendants also contend that the case should be heard elsewhere
because the Philadelphia County courts are too congested to handle it
promptly. This argument is largely based on facts which cannot be considered
on appeal for lack of a basis in the certified record. In addition, the record
contains no information about the caseloads of alternative forums, so it is
impossible to compare their respective capacities.


                                           -8-
J-A22040-19


justice strongly militates in favor of relegating the plaintiff to another forum.”

Poley v. Delmarva Power and Light Co., 779 A.2d 544, 546 (Pa. Super.

2001) (emphasis in original).

      To determine if “weighty reasons” overcome the deference afforded to

a plaintiff’s choice of forum, the trial court must examine both the private and

public interest factors involved in the case. The private factors include:

      the relative ease of access to sources of proof; availability of
      compulsory process for attendance for unwilling, and the cost of
      obtaining attendance of willing, witnesses; possibility of view of
      the premises, if view would be appropriate to the action; and all
      other practical problems that make trial of a case easy,
      expeditious and inexpensive.

Farley v. McDonnell Douglas Truck Servs., Inc., 638 A.2d 1027, 1030

(Pa. Super. 1994) (quoting Plum v. Tampax, Inc., 160 A.2d 549, 533 (Pa.

1960)).

      As to the public factors, trial courts must take into account several

circumstances, including that:

      administrative difficulties follow for courts when litigation is piled
      up in congested centers instead of being handled at its origin. Jury
      duty is a burden that ought not to be imposed upon the people of
      a community which has no relation to the litigation. There is an
      appropriateness, too, in having the trial . . . in a forum that is at
      home with the state law that must govern the case, rather than
      having a court in some other forum untangle problems in conflict
      of laws, and in law foreign to itself.

Id.; D’Alterio v. New Jersey Transit Rail Operations, Inc., 845 A.2d 850,

852 (Pa. Super. 2004) (same).




                                      -9-
J-A22040-19


       With respect to these factors, a defendant must show that the plaintiff’s

chosen forum is inconvenient to the defendant.7 A defendant cannot merely

assert that dismissal is warranted because the chosen forum is inconvenient

to the plaintiff in some way. Accordingly, it is difficult for a defendant to show

that convenience is a factor that weighs in favor of dismissal where it is

headquartered in the chosen forum, even if the plaintiff resides elsewhere.

See Vaughan Estate of Vaughan v. Olympus Am., Inc., 208 A.3d 66, 77

(Pa. Super. 2019) (“In our view, any difficulty a plaintiff faces in securing

evidence necessary to prove a cause of action is not a valid reason to override

the plaintiff’s forum preference.”) (emphasis in original).8

                                               B.

       In conducting our review, we cannot reverse a “trial court’s decision to

dismiss based on forum non conveniens . . . absent an abuse of discretion.”



____________________________________________


7 It is unnecessary to assess whether an alternative forum is available for
McConnell’s claims because the Braun Defendants have stipulated to
jurisdiction in Texas or Michigan. See Jessop v. ACF Industries, LLC, 859
A.2d 801, 803 (Pa. Super. 2004) (citation omitted) (“A stipulation made by a
defendant that he or she will submit to service of process and not raise the
statute of limitations as a defense has been accepted by the courts as
eliminating the concern regarding the availability of an alternate forum.”).

8 The respective locations of parties, witnesses and evidence may bear on the
public factor of whether a forum has an interest in the suit, as well as the
private factor of whether the circumstances at hand would make a trial in the
plaintiff’s chosen forum “easy, expeditious and inexpensive.” Farley v.
McDonnell Douglas Truck Servs., Inc., 638 A.2d 1027, 1030 (Pa. Super.
1994).


                                          - 10 -
J-A22040-19


Bochetto v. Dimeling, Schreiber & Park, 151 A.3d 1072, 1079 (Pa. Super.

2016) (citation omitted).       An abuse of discretion occurs if “the law is

overridden   or   misapplied,    or   the   judgment   exercised   is   manifestly

unreasonable, or the result of partiality, prejudice, bias, or ill will.”     Id.

(quoting Aerospace Finance Leasing, Inc. v. New Hampshire Ins. Co.,

696 A.2d 810, 812 (Pa. Super. 1997)). A trial court’s decision will stand if

there is any basis in the record to support it. Id.; Farley, 638 A.2d at 1029.

      Importantly, the party seeking dismissal has the burden of proof.

Shifting that initial burden to the party opposing dismissal and making

presumptions about the evidence against the non-moving party constitute an

abuse of discretion because it is a misapplication of the governing legal

standard. See Humes v. Eckerd Corp., 807 A.2d 290, 296 (Pa. Super. 2002)

(“To assume that the facts pleaded in the New Jersey complaint would be

identical to those filed in a complaint filed in Philadelphia County is not

appropriate.”).

      A trial court also misapplies the law in this context by incorrectly

weighing the public and private factors. See Plum, 160 A.2d at 554 (“Proper

application of the doctrine of Forum Non Conveniens necessitates that the

court below make a finding as to the availability of other forums and then

exercise its discretion after considering all the factors.”); Wright v. Aventis

Pasteur, Inc., 905 A.2d 544, 550 (Pa. Super. 2006) (“The trial judge . . . did

not discuss the arguments presented by appellants, but focused primarily on


                                       - 11 -
J-A22040-19


the parties’ lack of ties to [Pennsylvania].”); Bochetto, 94 A.3d at 1054

(abuse of discretion for trial court to engage in “one-sided discussion” of

factors weighing against plaintiff’s choice of forum); Vaughan, 208 A.3d at

77 (reversing dismissal order where the public and private factors supported

the plaintiff’s chosen forum).

      Because the burden of establishing the factors of forum non conveniens

lies with the Braun Defendants, it was up to them and not McConnell to show

that Pennsylvania is less convenient than another available forum. The trial

court could not assume facts that are not contained in the certified record or

otherwise put the burden on McConnell to show that private and public factors

support keeping this case in Pennsylvania.      Nor could the trial court focus

exclusively on this case’s remoteness from Pennsylvania without weighing

them against the relevant circumstances which link this case to Pennsylvania.

If it does so, it is an abuse of discretion.

                                        III.

                                         A.

      As to the private interest factors of forum non conveniens, the Braun

Defendants focus heavily on the claim that McConnell’s medical care providers

will be critical for establishing whether she has, in fact, been injured by the

VenaTech Filter, and, if so, the extent of her damages. However, the Braun

Defendants have not specifically identified any such witnesses and nothing in

the record suggests that such witnesses will refuse to attend the trial. No


                                       - 12 -
J-A22040-19


discovery has taken place yet so the need for and import of such testimony is

far from settled. The trial court could not justify this case’s dismissal with an

assumption that there are indispensable witnesses in Texas whose presence

at trial is in doubt.

      More importantly, the Braun Defendants cannot rely on potential

inconveniences to McConnell as a basis for dismissal on the grounds of forum

non conveniens. As the plaintiff, McConnell has the burden of proof at trial as

to causation and damages, making it her obligation to procure evidence to

that effect. If McConnell is unable to elicit the evidence she needs to prove

her case, then it is a benefit to the Braun Defendants, not an inconvenience.

See Vaughan, 208 A.3d at 77 (“Moreover, the trial court’s concern that

[plaintiff’s] fact witnesses for damages are located in North Carolina is not

persuasive. In our view, any difficulty a plaintiff faces in securing evidence

necessary to prove a cause of action is not a valid reason to override the

plaintiff’s forum preference.”) (Emphasis in original, citation omitted).

      Next, in addressing the private factors, the trial court did not consider

the presence of BIS employees in Lehigh County. It discounted that evidence

because the Braun Defendants only submitted the affidavits of those witnesses

in support of the motion to transfer the case and not their motion to dismiss.

See Trial Court Opinion, at 3, 10. The trial court abused its discretion in not

considering the affidavits because, regardless of why that evidence was




                                     - 13 -
J-A22040-19


introduced, it showed that Pennsylvania is more convenient for the Braun

Defendants than either Texas or Michigan.

          In his affidavit, BIS’s president admitted that several employees who

reside in Lehigh County are potential trial witnesses.        These employees

personally engaged in the sale, distribution and marketing of the VenaTech

Filter.    Such conduct will indisputably be of great interest at trial.   If, for

example, those BIS employees were privy to defects in the device and still

marketed it as safe, the conduct would be highly pertinent to McConnell’s

claims. These BIS employees are all the more germane to the private factors

of forum non conveniens because moving the case to Texas or Michigan would

take away from McConnell the relative ease of access both to witnesses and

other sources of proof, increasing the practical problems that make trial of a

case easy, expeditious and inexpensive. The affidavits confirm this lack of

relative access because they amounted to an admission that Texas or Michigan

would be far more burdensome forums for them than Pennsylvania.9

          The Braun Defendants also contend that Philadelphia is an inconvenient

forum because many of McConnell’s claims hinge on evidence located in


____________________________________________


9 In several affidavits, BIS employees outlined how a trial in Philadelphia
County would be extremely disruptive to their lives in Lehigh County. This is
compelling evidence that holding the trial in Texas or Michigan would be even
more difficult for these potential witnesses and, therefore, less convenient for
the Braun Defendants. The trial court did not at all consider this evidence
showing that Pennsylvania is a more convenient and appropriate forum for
McConnell’s trial than Texas or Michigan.


                                          - 14 -
J-A22040-19


France, and that the distance between Pennsylvania and that locale may pose

logistical difficulties. However, for the purposes of forum non conveniens in

this case, the French connection is a wash. The Braun Defendants do not

suggest that McConnell must seek relief in a European court. The parties and

the trial court agreed that McConnell should be able to file suit somewhere in

the United States.

      This means that any domestic venue – whether in Pennsylvania, Texas

or Michigan – would be equally remote from evidence of a design and

manufacturing defect in France. See generally Farley, 638 A.2d at 1031

(“The burdens of trying this case in New York appear to be equal to the

burdens of trying the case in Philadelphia, Pennsylvania. Regardless of where

the case is tried, witnesses and documents are going to have to be brought

from the other state.”); D'Alterio, 845 A.2d at 854 (dismissal was abuse of

discretion in part because defendant “failed to allege that its access to sources

of proof or to witnesses would be impeded by trial in [plaintiff’s chosen

forum].”).

      BMI and BIS both have corporate offices in Pennsylvania; so in terms of

convenience for those defendants, that forum state seems as good as any

other. See Wright, 905 A.2d at 551 (“In fact, Philadelphia County, with its

proximity to the relevant corporate offices of four appellees-defendants,

appears to be quite a convenient jurisdiction for the trial of the case.”). While

the Braun Defendants argue that Philadelphia County will be overburdened by


                                     - 15 -
J-A22040-19


numerous other VenaTech Filter cases, it appears that litigating all the claims

in one place, near their corporate offices, would be much more convenient

than litigating those cases in countless jurisdictions simultaneously.10

       The Braun Defendants’ application of law concerns are of no moment

because the record does not suggest that any forum would make a trial more

or less convenient in this respect. In their briefs, the parties agree that the

law of McConnell’s home state of Texas is likely controlling.        The Braun

Defendants have not shown how the application of Texas law could make a

difference in the outcome of this suit.11 The trial court could not find that it

would be inconvenient or undesirable for a Pennsylvania court to apply the

law of another jurisdiction without evidence that the law of the two forums is



____________________________________________


10 The Braun Defendants have argued that Philadelphia County may soon be
flooded by hundreds of products liability suits regarding the VenaTech Filter.
They suggest that such a burden vastly outweighs any public interest the
forum might have in hosting such cases. There is no evidence in this record
that the Court of Common Pleas of Philadelphia County does not have an
ability to expeditiously handle mass torts – when, in fact, it has a Mass Tort
Section to do so.

11 The trial court weighed the fact that a Pennsylvania court lacks subpoena
power over non-party Texas witnesses but did not consider the Texas laws
that govern McConnell’s products liability claims. This further illustrates that
the trial court did not fully weigh all relevant factors or hold the Braun
Defendants to their burden of proving that another state is a more suitable
forum than Pennsylvania. Had the trial court done so, it would have become
apparent that Texas and Pennsylvania have both adopted the Second
Restatement (Torts) for products liability claims. See Tincher v. Omega
Flex, Inc., A.3d 328, 400 (Pa. 2014); Clay v. AIG Aerospace Ins. Servs.,
Inc., 488 S.W.3d 402, 407 (Tex. App. 2016).


                                          - 16 -
J-A22040-19


materially different in some way or cumbersome for a judge in that forum to

apply. See id. at 551 (“[T]here is no basis upon which to conclude that the

law determined to be applicable is beyond the ken of a Philadelphia trial

judge.”).

                                               B.

       We now turn to the relevant public factors.        Although Texas and

Michigan have an obvious interest in the health of their residents and the

performance of their physicians, Pennsylvania’s interests are implicated as

well. If held in Pennsylvania, a trial would determine whether corporations

with a principal place of business and a headquarters located within it have

sold, marketed and distributed a product that may have injured people across

the country.     The trial court abused its discretion as to the public factors

because it disregarded Pennsylvania’s interests and improperly focused on

whether Philadelphia is a convenient forum.12

       It is undisputed that a number of BIS employees work and reside in

Pennsylvania. These witnesses may have personal knowledge about matters

which relate to McConnell’s case, such as the sale, marketing, distribution and

post-market surveillance of the VenaTech Filter, a product shipped all over the



____________________________________________


12 The trial court’s opinion and the Braun Defendants’ brief tend to conflate
(a) a motion to dismiss the case from Pennsylvania with (b) a motion to
transfer the case from Philadelphia County to Lehigh County. A case’s lack of
connection to one county does not justify dismissal from the entire state.


                                          - 17 -
J-A22040-19


country, including in Pennsylvania.    BMI and BIS both maintain corporate

offices in Lehigh County.    The trial court did not analyze Pennsylvania’s

interest in the outcome of the case with those meaningful ties in mind.

      In Wright, this Court emphasized that a products liability case should

not be dismissed due to lack of ties to a particular county when a defendants’

marketing decisions have a statewide or national impact:

      With regard to the public factors, this litigation involves seven
      pharmaceutical companies that market vaccines and immune
      globulin products in Pennsylvania. Thus, there is little support for
      the conclusion that the people of Pennsylvania have no interest in
      this case, particularly since appellants aver that several of these
      in the Commonwealth.

Wright, 905 A.2d at 551; see also Vaughan, 208 A.3d at 77 (finding public

interest factors established where the defendants were “Pennsylvania-based

. . . companies [that] maintain robust sales and marketing departments in

Pennsylvania.”)

      Wright’s discussion of public interest factors as to nationally distributed

medical products applies squarely to the scenario now before us.             The

VenaTech Filter was designed and manufactured in France, but the marketing,

sale and post-market surveillance of the product from within Pennsylvania is

the crux of many of McConnell’s claims.       This type of corporate action is

compelling evidence of a public interest factor that must be considered in an

analysis of forum non conveniens. See Hunter v. Shire US, Inc., 992 A.2d

891 (Pa. Super. 2010) (“There is no question that the central issue herein

relates to Appellant’s development, testing, and marketing of Adderall, and its

                                     - 18 -
J-A22040-19


knowledge of and warnings about the risks of heart attack from ingesting that

drug. The events relating to these activities were conducted by Appellant’s

employees in Pennsylvania.”).

       The trial court abused its discretion because it gave no weight to many

relevant factors and too much weight to irrelevant ones.           The Braun

Defendants, as the parties moving for dismissal, did not carry their burden of

showing why a trial in Pennsylvania would be inconvenient. Because the trial

court misapplied the law and the circumstances of this case do not warrant

dismissal, the order on review must be reversed. See Vaughan, 208 A.3d at

77 (“In sum, faced with private and public factors that clearly support

Vaughan’s choice to proceed in Philadelphia, we conclude there were not

weighty reasons to disturb [plaintiff’s] choice of forum.”).13 However, because

____________________________________________


13The Braun Defendants and the trial court both rely on Engstrom v. Bayer
Corp., 855 A.2d 52 (Pa. Super. 2004), a case that involved the ingestion of
Alka-Seltzer     Plus,   which    contained     a   decongestant    ingredient,
phenylpropanolamine (PPA), that caused users to suffer a hemorrhagic stroke.
The plaintiffs in that case did not reside in Pennsylvania and the product was
not designed or manufactured in Pennsylvania. Engstrom, 855 A.2d at 54.
While the defendant in Engstrom had corporate headquarters in
Pennsylvania, it was incorporated in Indiana, where the medication was
developed and produced. Id. In 1995, the division that developed and
produced the medication relocated to New Jersey. Id. Only one material
witness was located in Pennsylvania. Id. In this case, unlike in Engstrom,
there are several potential trial witnesses with material personal knowledge
who have averred that a trial outside of Pennsylvania would be extremely
burdensome. Moreover, the foreign jurisdiction where the allegedly defective
product was designed and manufactured is another country rather than
another state. Considering all that, the facts of the present case are more
akin to those in the more recent opinions. See Vaughan Estate of Vaughan



                                          - 19 -
J-A22040-19


the issue of transfer from Philadelphia County to Lehigh County is not before

us, the Braun Defendants’ pending motion may be considered by the trial court

on remand.

       Order vacated; case remanded. Jurisdiction relinquished.

Judgment Entered.




Joseph D. Seletyn, Esq.
Prothonotary



Date: 10/16/19




____________________________________________


v. Olympus Am., Inc., 208 A.3d 66, 77 (Pa. Super. 2019); Hunter v. Shire
US, Inc., 992 A.2d 891 (Pa. Super. 2010); and Wright v. Aventis Pasteur,
Inc., 905 A.2d 544 (Pa. Super. 2006).

                                          - 20 -
